Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05899361

A Pilot Study of a Novel Imaging Protocol to Identify Lymph Nodes and Organs of Interest for Surgical Dissection in Urologic Cancers

Led by Dana-Farber Cancer Institute · Updated on 2023-10-24

10

Participants Needed

1

Research Sites

69 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

S

Siemens Medical Solutions

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research evaluates a new imaging method combining electromagnetic tracking with laparoscope and ultrasound probe imaging to improve surgeries for patients with confirmed urologic cancers. These cancers may affect the bladder, prostate, testicle, kidney, urethra, penis, ureter, or scrotum. The study aims to enhance visualization and localization of affected areas during lymph node dissection or organ removal surgeries, potentially reducing complexity, complications, and improving outcomes. Participants will undergo surgeries using a standard laparoscope and ultrasound probe equipped with an electromagnetic sensor to track lymph nodes or organs of interest. This imaging protocol is expected to record data in under 10 minutes during the procedure. The study is a pilot trial involving 10 participants and is supported by Siemens Medical USA. Participants will be monitored through laparoscope and ultrasound images and electromagnetic tracking data over one year. Researchers will assess the accuracy of navigation retrospectively. The involvement includes scheduled surgeries with laparoscopic lymph node dissection and/or organ removal, supported by imaging and tracking to evaluate this novel approach. The study is led by Dana-Farber Cancer Institute and runs until December 2026.

CONDITIONS

Brief Title

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent before any trial-related procedures
  • Age 18 years or older
  • Confirmed or suspected urologic disease with scheduled confirmatory surgical biopsy
  • Recent CT, PET, or MR scan of acceptable quality within the past year
  • Scheduled for lymph node dissection or organ removal surgery in urologic regions (Bladder, Prostate, Testicle, Ureter, Kidney, Urethra, Penis, Scrotum)
  • Scheduled to undergo laparoscopic lymph node dissection and/or urologic organ removal at Brigham and Women's Hospital
Not Eligible

You will not qualify if you...

  • Severely impaired kidney function with EGFR less than 30 mL/min/body surface area
  • Significant uncontrolled medical conditions that affect protocol compliance or result interpretation
  • History of hypersensitivity or contraindication to contrast media
  • Contraindication to general anesthesia
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Surgery day and less than 10 minutes for data recording

Participants undergo a standard laparoscopic lymph node dissection and/or urologic organ removal surgery using a laparoscope and ultrasound probe equipped with an electromagnetic sensor to assist in tracking lymph nodes and organs of interest.

1 surgical visit

Long-term Monitoring

Duration - 1 year

Participants' laparoscope and ultrasound images, as well as electromagnetic tracking data, are collected and analyzed over 1 year to assess outcomes and navigation accuracy.

Visits as per standard follow-up care

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

M

Matthew Mossanen, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With...

Prostate Cancer

Actively Recruiting

1 location

A Phase 1b Study of 177Lu-PSMA-617 Combined With Liver Direc...

Metastatic Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here